The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Aging and Parkinson's disease: Different sides of the same coin?
Open accessAbstract
Despite abundant epidemiological evidence in support of aging as the primary risk factor for PD, biological correlates of a connection have been elusive. In this article, we address the following question: does aging represent biology accurately characterized as pre‐PD? We present evidence from our work on midbrain dopamine neurons of aging nonhuman primates that demonstrates that markers of known correlates of dopamine neuron degeneration in PD, including impaired proteasome/lysosome function, oxidative/nitrative damage, and inflammation, all increase with advancing age and are exaggerated in the ventral tier substantia nigra dopamine neurons most vulnerable to degeneration in PD. Our findings support the view that aging‐related changes in the dopamine system approach the biological threshold for parkinsonism, actively producing a vulnerable pre‐parkinsonian state. © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
A C. elegans mutant that lives twice as long as wild type
Kenyon, C., Chang, J., Gensch, E., Rudner, A., & Tabtiang, R. (1993) · Nature · doi:10.1038/366461a0 · Cited by 3,387
The prevalence of Parkinson's disease: a systematic review and meta-analysis
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
Motor control and aging: Links to age-related brain structural, functional, and biochemical effects
Seidler, R. D., Bernard, J. A., Burutolu, T. B., Fling, B. W., Gordon, M. T., Gwin, J. T., Kwak, Y., & Lipps, D. B. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.10.005 · Cited by 1,791
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy‐Agid, F., Agid, Y., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397
Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease
Ibáñez, P., Bonnet, A.-M., Débarges, B., Lohmann, E., Tison, F., Agid, Y., Dürr, A., Brice, A., & Pollak, P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17104-3 · Cited by 1,044
Alam, Z. I., Jenner, A., Daniel, S. E., Lees, A. J., Cairns, N., Marsden, C. D., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031196.x · Cited by 845 · cited 2×
“Postmortem PD brains exhibit an increase in markers of oxidative damage to proteins,41 lipids,42 and DNA.43 DA neurons are inherently vulnerable to these stressors in part because of the high potential for auto-oxidation of intracellular DA that is not efficiently sequestered into synaptic vesicles.44,45 We examined t…”
BackgroundImamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791
Human iPSC-based modeling of late-onset disease via progerin-induced aging
Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., Mandal, P. K., Vera, E., Shim, J.-W., Kriks, S., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.006 · Cited by 777
LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress
Nguyen, H. N., Byers, B., Cord, B., Shcheglovitov, A., Byrne, J., Gujar, P., Kee, K., Schüle, B., Dolmetsch, R. E., Langston, W., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.01.013 · Cited by 745
Brunk, U. T., & Terman, A. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02869.x · Cited by 726
Prevalence of Parkinsonian Signs and Associated Mortality in a Community Population of Older People
Bennett, D. A., Beckett, L. A., Murray, A. M., Shannon, K. M., Goetz, C. G., Pilgrim, D. M., & Evans, D. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601113340202 · Cited by 659
Epidemiology of parkinson’s disease
Tanner, C. M., & Goldman, S. M. (1996) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70259-0 · Cited by 640
Spira, P. J., Sharpe, D. M., Halliday, G., Cavanagh, J., & Nicholson, G. A. (2001) · Annals of Neurology · doi:10.1002/ana.67 · Cited by 627
PINK1/Parkin-mediated mitophagy in mammalian cells
Eiyama, A., & Okamoto, K. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.01.002 · Cited by 603
Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease
Sulzer, D. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.009 · Cited by 587
Gibb, W. R., & Lees, A. J. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.5.388 · Cited by 574
Altered proteasomal function in sporadic Parkinson’s disease
St. P. McNaught, K., Belizaire, R., Isacson, O., Jenner, P., & Olanow, C. W. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8050 · Cited by 573
Alam, Z. I., Daniel, S. E., Lees, A. J., Marsden, D. C., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031326.x · Cited by 547
Cooper, O., Seo, H., Andrabi, S., Guardia-Laguarta, C., Graziotto, J., Sundberg, M., McLean, J. R., Carrillo-Reid, L., Xie, Z., Osborn, T., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003985 · Cited by 508
AETIOLOGY OF PARKINSON'S DISEASE
Calne, D., & William Langston, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90802-4 · Cited by 469
Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates
Collier, T. J., Kanaan, N. M., & Kordower, J. H. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3039 · Cited by 449
Self-citationFunctional Decline in Parkinson Disease
Jankovic, J., & Kapadia, A. S. (2001) · Archives of Neurology · doi:10.1001/archneur.58.10.1611 · Cited by 427
Chu, Y., Dodiya, H., Aebischer, P., Olanow, C. W., & Kordower, J. H. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.023 · Cited by 421
Self-citationThe three ‘P’s of mitophagy: PARKIN.; PINK1.; and post-translational modifications
Durcan, T. M., & Fon, E. A. (2015) · Genes & Development · doi:10.1101/gad.262758.115 · Cited by 400
Chu, Y., & Kordower, J. H. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.021 · Cited by 396
Self-citationReduced Vesicular Storage of Dopamine Causes Progressive Nigrostriatal Neurodegeneration
Caudle, W. M., Richardson, J. R., Wang, M. Z., Taylor, T. N., Guillot, T. S., McCormack, A. L., Colebrooke, R. E., Di Monte, D. A., Emson, P. C., & Miller, G. W. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0319-07.2007 · Cited by 388
Seibler, P., Graziotto, J., Jeong, H., Simunovic, F., Klein, C., & Krainc, D. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4441-10.2011 · Cited by 378
Dettmer, U., Newman, A. J., Soldner, F., Luth, E. S., Kim, N. C., von Saucken, V. E., Sanderson, J. B., Jaenisch, R., Bartels, T., & Selkoe, D. (2015) · Nature Communications · doi:10.1038/ncomms8314 · Cited by 317
Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H., & Nagatsu, T. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050028 · Cited by 282
Lewy Bodies of Parkinson's Disease Contain Neurofilament Antigens
Goldman, J. E., Yen, S.-H., Chiu, F.-C., & Peress, N. S. (1983) · Science · doi:10.1126/science.6308771 · Cited by 260
McNaught, K. S. P., Belizaire, R., Jenner, P., Olanow, C. W., & Isacson, O. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00296-3 · Cited by 232
Nurr1 in Parkinson's disease and related disorders
Chu, Y., Le, W., Kompoliti, K., Jankovic, J., Mufson, E. J., & Kordower, J. H. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20828 · Cited by 224
Self-citationImmunochemical Analysis of Vesicular Monoamine Transporter (VMAT2) Protein in Parkinson's Disease
Miller, G. W., Erickson, J. D., Perez, J. T., Penland, S. N., Mash, D. C., Rye, D. B., & Levey, A. I. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.7008 · Cited by 215
Lewy Body Pathology in Normal Elderly Subjects
Markesbery, W. R., Jicha, G. A., Liu, H., & Schmitt, F. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ac10a7 · Cited by 210
CLINICAL RELEVANCE OF SPECIFIC IgG ANTIBODIES TO CARDIOLIPIN
Faux, J. A., Byron, M. A., & Chapel, H. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92069-2 · Cited by 165
Collier, T. J., Lipton, J., Daley, B. F., Palfi, S., Chu, Y., Sortwell, C., Bakay, R. A. E., Sladek, J. R., & Kordower, J. H. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.11.013 · Cited by 162
Self-citationZhu, J., Kulich, S. M., Oury, T. D., & Chu, C. T. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64487-2 · Cited by 153
Parkinson Disease With Old-Age Onset
Diederich, N. J., Moore, C. G., Leurgans, S. E., Chmura, T. A., & Goetz, C. G. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.529 · Cited by 147
Aging and the nigrostriatal dopamine system: a non-human primate study.
Irwin, I., DeLanney, L. E., McNeill, T. H., Chan, P., Forno, L. S., Murphy, G. M., Monte, D. A. D., Sandy, M. S., & Jw, L. (1994) · PubMed · Cited by 125
Aging of the nigrostriatal system in the squirrel monkey
McCormack, A. L., Monte, D. A. D., Delfani, K., Irwin, I., DeLanney, L. E., Langston, J. W., & Janson, A. M. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20036 · Cited by 120
Histological changes of the dopaminergic nigrostriatal system in aging
Stark, A. K., & Pakkenberg, B. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0972-9 · Cited by 109
Etiology of Parkinson’s Disease: A Research Strategy
Barbeau, A. (1984) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100045273 · Cited by 109
Delaying aging is neuroprotective in Parkinson’s disease: a genetic analysis in C. elegans models
Cooper, J. F., Dues, D. J., Spielbauer, K. K., Machiela, E., Senchuk, M. M., & Raamsdonk, J. M. V. (2015) · npj Parkinson s Disease · doi:10.1038/npjparkd.2015.22 · Cited by 108
Glorioso, C. A., Oh, S., Douillard‐Guilloux, G., & Sibille, E. L. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.09.016 · Cited by 105
González‐Hernández, T., Barroso‐Chinea, P., Cruz‐Muros, I., Pérez-Delgado, M. D. M., & Rodríguez, M. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20323 · Cited by 102
Kordower, J. H., Goetz, C. G., Chu, Y., Halliday, G. M., Nicholson, D. A., Musial, T. F., Marmion, D. J., Stoessl, A. J., Sossi, V., Freeman, T. B., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24820 · Cited by 93
Self-citationAge at onset: the major determinant of outcome in Parkinson's disease
Hely, M. A., Morris, J. G., Reid, W., O'Sullivan, D. J., Williamson, P. M., Broe, G. A., & ADENA, M. A. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1995.tb00480.x · Cited by 88
Collier, T. J., Sortwell, C. E., & Daley, B. F. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05563.1999 · Cited by 85
Self-citationKanaan, N. M., Kordower, J. H., & Collier, T. J. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21333 · Cited by 83
Self-citationAge-related changes in glial cells of dopamine midbrain subregions in rhesus monkeys
Kanaan, N. M., Kordower, J. H., & Collier, T. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.006 · Cited by 80
Self-citationStriatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism
Collier, T. J., Ling, Z. D., Carvey, P. M., Fletcher, A. M., Yurek, D. M., Sladek, J. R., & Kordower, J. H. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.08.018 · Cited by 80
Self-citationThe aging striatal dopamine function.
Darbin, O. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.11.025 · Cited by 79
Kanaan, N. M., Kordower, J. H., & Collier, T. J. (2008) · Glia · doi:10.1002/glia.20690 · Cited by 67
Self-citationKästner, A., Hirsch, É. C., Herrero, M. T., Javoy-Agid, F., & Agid, Y. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03616.x · Cited by 64
Age-associated changes in rhesus CNS composition identified by MRI
Andersen, A. H., Zhang, Z., Zhang, M., Gash, D. M., & Avison, M. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01343-8 · Cited by 64
Walia, B., Satija, N. K., Tripathi, R. P., & Gangenahalli, G. U. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9279-x · Cited by 62
Pathogenesis of Parkinson's Disease
Mann, D. M. A., & Yates, P. O. (1982) · Archives of Neurology · doi:10.1001/archneur.1982.00510210015004 · Cited by 51
Kanaan, N. M., Kordower, J. H., & Collier, T. J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06307.x · Cited by 49
Self-citationOlanow, C. W., & Kordower, J. H. (2009) · Annals of Neurology · doi:10.1002/ana.21832 · Cited by 47
Self-citationA stereological study of substantia nigra in young and old rhesus monkeys
Pakkenberg, H., Andersen, B. B., Burns, R. S., & Pakkenberg, B. (1995) · Brain Research · doi:10.1016/0006-8993(95)00678-j · Cited by 44
Collier, T. J., O’Malley, J. A., Rademacher, D. J., Stancati, J. A., Sisson, K. A., Sortwell, C. E., Paumier, K. L., Gebremedhin, K. G., & Steece‐Collier, K. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.005 · Cited by 28
Self-citationAltered lipofuscin pigmentation in the basal nucleus (Meynert) in Parkinson's disease
Ulfig, N. (1989) · Neuroscience Research · doi:10.1016/0168-0102(89)90007-2 · Cited by 18
Cited by
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Trist, B. G., Hare, D. J., & Double, K. L. (2019) · Aging Cell · doi:10.1111/acel.13031 · Cited by 778
Determinants of dopaminergic neuron loss in Parkinson's disease
Surmeier, D. J. (2018) · The FEBS Journal · doi:10.1111/febs.14607 · Cited by 444
Pang, S. Y.-Y., Ho, P. W.-L., Liu, H.-F., Leung, C.-T., Li, L., Chang, E. E. S., Ramsden, D. B., & Ho, S.-L. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0165-9 · Cited by 427
The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases
Jiao, F., & Gong, Z. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6782872 · Cited by 288
The Kaleidoscope of Microglial Phenotypes
Dubbelaar, M. L., Kracht, L., Eggen, B. J. L., & Boddeke, E. W. G. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01753 · Cited by 260
Metadata
- Authors
- Collier, T. J., Kanaan, N. M., & Kordower, J. H.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2017-05-18
- Volume
- 32
- Issue
- 7
- Pages
- 983-990
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2614383142
- Cited by
- 268
- References
- 68
- FWCI
- 13.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.